Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
| UnnamedSample_HQ_transcript/67384|m.17471 | UnnamedSample_HQ_transcript/67384 | Coverage 0.780 too low. | 6ef0792766ff2dbc16f306620d2f84cf | 376 | Pfam | PF08623 | TATA-binding protein interacting (TIP20) | 183 | 346 | 1.8E-63 | T | 22-09-2020 | IPR013932 | TATA-binding protein interacting (TIP20) |
| UnnamedSample_HQ_transcript/91485|m.21471 | UnnamedSample_HQ_transcript/91485 | Coverage 0.968 too low. | daeca42069a82daa7e2675257debfb09 | 285 | Pfam | PF00505 | HMG (high mobility group) box | 66 | 117 | 9.4E-9 | T | 22-09-2020 | IPR009071 | High mobility group box domain |
| UnnamedSample_HQ_transcript/33090|m.10229 | UnnamedSample_HQ_transcript/33090 | Coverage 0.987 too low. | d6200ec99b526117e3a844d90f250eb3 | 802 | Pfam | PF03165 | MH1 domain | 28 | 129 | 1.1E-19 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/73367|m.18535 | UnnamedSample_HQ_transcript/73367 | Coverage 0.777 too low. | 35264718f1f6a29b002e093fdd6d0769 | 459 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.6E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/20437|m.6984 | UnnamedSample_HQ_transcript/20437 | Coverage 0.930 too low. | b27e4094b58378fc50b86b1eb6603977 | 398 | Pfam | PF00640 | Phosphotyrosine interaction domain (PTB/PID) | 33 | 187 | 9.3E-36 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/20437|m.6984 | UnnamedSample_HQ_transcript/20437 | Coverage 0.930 too low. | b27e4094b58378fc50b86b1eb6603977 | 398 | Pfam | PF00017 | SH2 domain | 304 | 375 | 2.2E-16 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/18798|m.6528 | UnnamedSample_HQ_transcript/18798 | Coverage 0.905 too low. | b27e4094b58378fc50b86b1eb6603977 | 398 | Pfam | PF00640 | Phosphotyrosine interaction domain (PTB/PID) | 33 | 187 | 9.3E-36 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/18798|m.6528 | UnnamedSample_HQ_transcript/18798 | Coverage 0.905 too low. | b27e4094b58378fc50b86b1eb6603977 | 398 | Pfam | PF00017 | SH2 domain | 304 | 375 | 2.2E-16 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/43746|m.12652 | UnnamedSample_HQ_transcript/43746 | Coverage 0.890 too low. | b27e4094b58378fc50b86b1eb6603977 | 398 | Pfam | PF00640 | Phosphotyrosine interaction domain (PTB/PID) | 33 | 187 | 9.3E-36 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/43746|m.12652 | UnnamedSample_HQ_transcript/43746 | Coverage 0.890 too low. | b27e4094b58378fc50b86b1eb6603977 | 398 | Pfam | PF00017 | SH2 domain | 304 | 375 | 2.2E-16 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/17151|m.6053 | UnnamedSample_HQ_transcript/17151 | Coverage 0.870 too low. | b27e4094b58378fc50b86b1eb6603977 | 398 | Pfam | PF00640 | Phosphotyrosine interaction domain (PTB/PID) | 33 | 187 | 9.3E-36 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/17151|m.6053 | UnnamedSample_HQ_transcript/17151 | Coverage 0.870 too low. | b27e4094b58378fc50b86b1eb6603977 | 398 | Pfam | PF00017 | SH2 domain | 304 | 375 | 2.2E-16 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/34919|m.10702 | UnnamedSample_HQ_transcript/34919 | Identity 0.822 too low. | a224908ab92289f4259bc445cc00ce73 | 706 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 125 | 160 | 1.1E-9 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/34919|m.10702 | UnnamedSample_HQ_transcript/34919 | Identity 0.822 too low. | a224908ab92289f4259bc445cc00ce73 | 706 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 209 | 247 | 3.1E-6 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/34919|m.10702 | UnnamedSample_HQ_transcript/34919 | Identity 0.822 too low. | a224908ab92289f4259bc445cc00ce73 | 706 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 165 | 199 | 2.9E-12 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/34919|m.10702 | UnnamedSample_HQ_transcript/34919 | Identity 0.822 too low. | a224908ab92289f4259bc445cc00ce73 | 706 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 81 | 116 | 6.7E-6 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/34919|m.10702 | UnnamedSample_HQ_transcript/34919 | Identity 0.822 too low. | a224908ab92289f4259bc445cc00ce73 | 706 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 506 | 541 | 5.3E-5 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/34919|m.10702 | UnnamedSample_HQ_transcript/34919 | Identity 0.822 too low. | a224908ab92289f4259bc445cc00ce73 | 706 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 463 | 498 | 1.9E-7 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/109150|m.23732 | UnnamedSample_HQ_transcript/109150 | Unmapped. | 4442b11cf3fd538bf43a48cb01708cf0 | 262 | Pfam | PF00378 | Enoyl-CoA hydratase/isomerase | 11 | 257 | 1.2E-32 | T | 22-09-2020 | IPR001753 | Enoyl-CoA hydratase/isomerase |
| UnnamedSample_HQ_transcript/91888|m.21524 | UnnamedSample_HQ_transcript/91888 | Coverage 0.357 too low. | 4442b11cf3fd538bf43a48cb01708cf0 | 262 | Pfam | PF00378 | Enoyl-CoA hydratase/isomerase | 11 | 257 | 1.2E-32 | T | 22-09-2020 | IPR001753 | Enoyl-CoA hydratase/isomerase |
| UnnamedSample_HQ_transcript/85613|m.20585 | UnnamedSample_HQ_transcript/85613 | Coverage 0.267 too low. | 4baad45f80276f4fbb6293b2004b73ff | 119 | Pfam | PF00049 | Insulin/IGF/Relaxin family | 31 | 113 | 4.1E-12 | T | 22-09-2020 | IPR016179 | Insulin-like |
| UnnamedSample_HQ_transcript/14794|m.5352 | UnnamedSample_HQ_transcript/14794 | Coverage 0.216 too low. | 23ccbe2a0441b5d1ecfb06702d96cde3 | 635 | Pfam | PF01130 | CD36 family | 92 | 381 | 7.2E-57 | T | 22-09-2020 | IPR002159 | CD36 family |
| UnnamedSample_HQ_transcript/14794|m.5352 | UnnamedSample_HQ_transcript/14794 | Coverage 0.216 too low. | 23ccbe2a0441b5d1ecfb06702d96cde3 | 635 | Pfam | PF01130 | CD36 family | 424 | 600 | 9.4E-34 | T | 22-09-2020 | IPR002159 | CD36 family |
| UnnamedSample_HQ_transcript/48443|m.13684 | UnnamedSample_HQ_transcript/48443 | Coverage 0.765 too low. | c0376b3ac30abe40f7fd2cb82cb5b62f | 664 | Pfam | PF00501 | AMP-binding enzyme | 109 | 578 | 2.7E-97 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/58525|m.15754 | UnnamedSample_HQ_transcript/58525 | Identity 0.898 too low. | 1ac21e1ea04aec37d368512c1affd0ce | 470 | Pfam | PF00069 | Protein kinase domain | 27 | 320 | 1.6E-40 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/33257|m.10277 | UnnamedSample_HQ_transcript/33257 | Coverage 0.456 too low. | d3daf0a54d1ae4610949220a9b6bf480 | 341 | Pfam | PF13424 | Tetratricopeptide repeat | 207 | 273 | 1.2E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/33257|m.10277 | UnnamedSample_HQ_transcript/33257 | Coverage 0.456 too low. | d3daf0a54d1ae4610949220a9b6bf480 | 341 | Pfam | PF13424 | Tetratricopeptide repeat | 103 | 158 | 1.0E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/33257|m.10277 | UnnamedSample_HQ_transcript/33257 | Coverage 0.456 too low. | d3daf0a54d1ae4610949220a9b6bf480 | 341 | Pfam | PF13176 | Tetratricopeptide repeat | 65 | 98 | 7.3E-6 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/79602|m.19643 | UnnamedSample_HQ_transcript/79602 | Coverage 0.749 too low. | 3782450f9deea9adbee0f7eef6bcf506 | 153 | Pfam | PF00400 | WD domain, G-beta repeat | 82 | 108 | 0.0062 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/79602|m.19643 | UnnamedSample_HQ_transcript/79602 | Coverage 0.749 too low. | 3782450f9deea9adbee0f7eef6bcf506 | 153 | Pfam | PF00400 | WD domain, G-beta repeat | 37 | 62 | 0.054 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/41182|m.12093 | UnnamedSample_HQ_transcript/41182 | Coverage 0.857 too low. | 3782450f9deea9adbee0f7eef6bcf506 | 153 | Pfam | PF00400 | WD domain, G-beta repeat | 82 | 108 | 0.0062 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/41182|m.12093 | UnnamedSample_HQ_transcript/41182 | Coverage 0.857 too low. | 3782450f9deea9adbee0f7eef6bcf506 | 153 | Pfam | PF00400 | WD domain, G-beta repeat | 37 | 62 | 0.054 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 596 | 687 | 2.1E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 1371 | 1443 | 1.2E-6 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 827 | 881 | 1.8E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 213 | 300 | 3.4E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 1265 | 1349 | 3.9E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 117 | 205 | 9.5E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 308 | 398 | 1.7E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 1173 | 1254 | 3.0E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 699 | 778 | 9.6E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 406 | 492 | 7.1E-20 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 1452 | 1537 | 1.4E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 1579 | 1667 | 5.5E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 499 | 589 | 4.2E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 891 | 973 | 1.5E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 1070 | 1156 | 8.1E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1830|m.993 | UnnamedSample_HQ_transcript/1830 | Coverage 0.466 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 22 | 105 | 1.3E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 596 | 687 | 2.1E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 1371 | 1443 | 1.2E-6 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 827 | 881 | 1.8E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 213 | 300 | 3.4E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 1265 | 1349 | 3.9E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 117 | 205 | 9.5E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 308 | 398 | 1.7E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 1173 | 1254 | 3.0E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 699 | 778 | 9.6E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 406 | 492 | 7.1E-20 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 1452 | 1537 | 1.4E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 1579 | 1667 | 5.5E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 499 | 589 | 4.2E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 891 | 973 | 1.5E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 1070 | 1156 | 8.1E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/2079|m.1089 | UnnamedSample_HQ_transcript/2079 | Coverage 0.451 too low. | 82b5182f7dc440b888a84b24a656c5d2 | 1670 | Pfam | PF00630 | Filamin/ABP280 repeat | 22 | 105 | 1.3E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/72157|m.18330 | UnnamedSample_HQ_transcript/72157 | Coverage 0.947 too low. | c464c93f7f015218dd3e082948f5aaed | 534 | Pfam | PF00262 | Calreticulin family | 57 | 430 | 2.1E-148 | T | 22-09-2020 | IPR001580 | Calreticulin/calnexin |
| UnnamedSample_HQ_transcript/20893|m.7120 | UnnamedSample_HQ_transcript/20893 | Coverage 0.989 too low. | 2b544e8f861d313a0ed991ec7d40695b | 974 | Pfam | PF06733 | DEAD_2 | 114 | 275 | 1.6E-50 | T | 22-09-2020 | IPR010614 | DEAD2 |
| UnnamedSample_HQ_transcript/20893|m.7120 | UnnamedSample_HQ_transcript/20893 | Coverage 0.989 too low. | 2b544e8f861d313a0ed991ec7d40695b | 974 | Pfam | PF13307 | Helicase C-terminal domain | 544 | 723 | 1.8E-55 | T | 22-09-2020 | IPR006555 | ATP-dependent helicase, C-terminal |
| UnnamedSample_HQ_transcript/105928|m.23327 | UnnamedSample_HQ_transcript/105928 | Unmapped. | ed97946f63838af4d6b3a45744a3516c | 321 | Pfam | PF08762 | CRPV capsid protein like | 34 | 183 | 3.9E-10 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/2845|m.1382 | UnnamedSample_HQ_transcript/2845 | Coverage 0.320 too low. | bc14603d02cd23a1e46548220d8e82a5 | 179 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 51 | 176 | 6.3E-15 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/21735|m.7350 | UnnamedSample_HQ_transcript/21735 | Coverage 0.082 too low. | f6d8dbf0adeba6973ee03e94473cd002 | 857 | Pfam | PF00400 | WD domain, G-beta repeat | 707 | 741 | 0.0089 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/21735|m.7350 | UnnamedSample_HQ_transcript/21735 | Coverage 0.082 too low. | f6d8dbf0adeba6973ee03e94473cd002 | 857 | Pfam | PF00400 | WD domain, G-beta repeat | 660 | 695 | 0.054 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/21735|m.7350 | UnnamedSample_HQ_transcript/21735 | Coverage 0.082 too low. | f6d8dbf0adeba6973ee03e94473cd002 | 857 | Pfam | PF00400 | WD domain, G-beta repeat | 819 | 855 | 0.025 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/21735|m.7350 | UnnamedSample_HQ_transcript/21735 | Coverage 0.082 too low. | f6d8dbf0adeba6973ee03e94473cd002 | 857 | Pfam | PF00400 | WD domain, G-beta repeat | 300 | 345 | 2.3E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/21735|m.7350 | UnnamedSample_HQ_transcript/21735 | Coverage 0.082 too low. | f6d8dbf0adeba6973ee03e94473cd002 | 857 | Pfam | PF03451 | HELP motif | 224 | 296 | 1.2E-31 | T | 22-09-2020 | IPR005108 | HELP |
| UnnamedSample_HQ_transcript/116789|m.24562 | UnnamedSample_HQ_transcript/116789 | Coverage 0.900 too low. | 9cf1ce6f22d9121152a4dba03abf259b | 154 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 108 | 153 | 0.0016 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/116789|m.24562 | UnnamedSample_HQ_transcript/116789 | Coverage 0.900 too low. | 9cf1ce6f22d9121152a4dba03abf259b | 154 | Pfam | PF07648 | Kazal-type serine protease inhibitor domain | 47 | 92 | 0.0017 | T | 22-09-2020 | IPR002350 | Kazal domain |
| UnnamedSample_HQ_transcript/9491|m.3668 | UnnamedSample_HQ_transcript/9491 | Coverage 0.104 too low. | 52c36b5700c31263cb0dafacacf06ebc | 1228 | Pfam | PF09469 | Cordon-bleu ubiquitin-like domain | 105 | 189 | 9.6E-6 | T | 22-09-2020 | IPR019025 | Cordon-bleu, ubiquitin-like domain |
| UnnamedSample_HQ_transcript/9129|m.3556 | UnnamedSample_HQ_transcript/9129 | Coverage 0.163 too low. | 8a7d67aba7f0d4c8b2a00ada3cb2b4fe | 1185 | Pfam | PF08264 | Anticodon-binding domain of tRNA ligase | 797 | 918 | 4.6E-14 | T | 22-09-2020 | IPR013155 | Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding |
| UnnamedSample_HQ_transcript/9129|m.3556 | UnnamedSample_HQ_transcript/9129 | Coverage 0.163 too low. | 8a7d67aba7f0d4c8b2a00ada3cb2b4fe | 1185 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 21 | 102 | 3.9E-15 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/9129|m.3556 | UnnamedSample_HQ_transcript/9129 | Coverage 0.163 too low. | 8a7d67aba7f0d4c8b2a00ada3cb2b4fe | 1185 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 186 | 757 | 2.9E-28 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/42697|m.12415 | UnnamedSample_HQ_transcript/42697 | Coverage 0.983 too low. | 83e64fa8a402fc899908a19f6eb2b4cb | 393 | Pfam | PF00069 | Protein kinase domain | 16 | 170 | 1.4E-18 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/18963|m.6567 | UnnamedSample_HQ_transcript/18963 | Coverage 0.808 too low. | b41a24124d299abc86ff88484f74ecb2 | 978 | Pfam | PF00307 | Calponin homology (CH) domain | 532 | 634 | 1.2E-15 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/18963|m.6567 | UnnamedSample_HQ_transcript/18963 | Coverage 0.808 too low. | b41a24124d299abc86ff88484f74ecb2 | 978 | Pfam | PF00412 | LIM domain | 904 | 961 | 2.1E-6 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/18963|m.6567 | UnnamedSample_HQ_transcript/18963 | Coverage 0.808 too low. | b41a24124d299abc86ff88484f74ecb2 | 978 | Pfam | PF00890 | FAD binding domain | 97 | 128 | 1.1E-5 | T | 22-09-2020 | IPR003953 | FAD-dependent oxidoreductase 2, FAD binding domain |
| UnnamedSample_HQ_transcript/22746|m.7630 | UnnamedSample_HQ_transcript/22746 | Coverage 0.986 too low. | 0d277be8d876ed615ebd8935b84445d7 | 973 | Pfam | PF00675 | Insulinase (Peptidase family M16) | 40 | 172 | 1.6E-38 | T | 22-09-2020 | IPR011765 | Peptidase M16, N-terminal |
| UnnamedSample_HQ_transcript/22746|m.7630 | UnnamedSample_HQ_transcript/22746 | Coverage 0.986 too low. | 0d277be8d876ed615ebd8935b84445d7 | 973 | Pfam | PF05193 | Peptidase M16 inactive domain | 675 | 853 | 2.3E-9 | T | 22-09-2020 | IPR007863 | Peptidase M16, C-terminal |
| UnnamedSample_HQ_transcript/22746|m.7630 | UnnamedSample_HQ_transcript/22746 | Coverage 0.986 too low. | 0d277be8d876ed615ebd8935b84445d7 | 973 | Pfam | PF05193 | Peptidase M16 inactive domain | 203 | 381 | 1.6E-24 | T | 22-09-2020 | IPR007863 | Peptidase M16, C-terminal |
| UnnamedSample_HQ_transcript/22746|m.7630 | UnnamedSample_HQ_transcript/22746 | Coverage 0.986 too low. | 0d277be8d876ed615ebd8935b84445d7 | 973 | Pfam | PF16187 | Middle or third domain of peptidase_M16 | 387 | 670 | 3.6E-100 | T | 22-09-2020 | IPR032632 | Peptidase M16, middle/third domain |
| UnnamedSample_HQ_transcript/70561|m.18024 | UnnamedSample_HQ_transcript/70561 | Coverage 0.723 too low. | 8e168578073b5e4595b62ea218882770 | 391 | Pfam | PF00096 | Zinc finger, C2H2 type | 249 | 271 | 8.0E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/70561|m.18024 | UnnamedSample_HQ_transcript/70561 | Coverage 0.723 too low. | 8e168578073b5e4595b62ea218882770 | 391 | Pfam | PF13912 | C2H2-type zinc finger | 282 | 307 | 0.0045 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/94188|m.21832 | UnnamedSample_HQ_transcript/94188 | Coverage 0.654 too low. | 72047d928b6a799ba9fc42c353bec8e3 | 352 | Pfam | PF15862 | Coilin N-terminus | 13 | 98 | 9.7E-10 | T | 22-09-2020 | IPR031722 | Coilin, N-terminal domain |
| UnnamedSample_HQ_transcript/80251|m.19756 | UnnamedSample_HQ_transcript/80251 | Identity 0.903 too low. | ae500a06ba4cf772b2c60689d2820f83 | 276 | Pfam | PF12210 | Hepatocyte growth factor-regulated tyrosine kinase substrate | 166 | 258 | 7.5E-41 | T | 22-09-2020 | IPR024641 | Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain |
| UnnamedSample_HQ_transcript/78709|m.19501 | UnnamedSample_HQ_transcript/78709 | Coverage 0.824 too low. | e05d7c660b21fe9517012dacb2d38622 | 423 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/84492|m.20417 | UnnamedSample_HQ_transcript/84492 | Identity 0.913 too low. | bd38110c37ba3a46d6e16c798ef07150 | 183 | Pfam | PF07679 | Immunoglobulin I-set domain | 33 | 123 | 2.2E-9 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/91497|m.21472 | UnnamedSample_HQ_transcript/91497 | Identity 0.908 too low. | bd38110c37ba3a46d6e16c798ef07150 | 183 | Pfam | PF07679 | Immunoglobulin I-set domain | 33 | 123 | 2.2E-9 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/67226|m.17447 | UnnamedSample_HQ_transcript/67226 | Coverage 0.891 too low. | 4c967b07e580c5c3f003d299299f9968 | 220 | Pfam | PF00431 | CUB domain | 3 | 96 | 4.3E-7 | T | 22-09-2020 | IPR000859 | CUB domain |
| UnnamedSample_HQ_transcript/67226|m.17447 | UnnamedSample_HQ_transcript/67226 | Coverage 0.891 too low. | 4c967b07e580c5c3f003d299299f9968 | 220 | Pfam | PF00431 | CUB domain | 152 | 200 | 1.8E-5 | T | 22-09-2020 | IPR000859 | CUB domain |
| UnnamedSample_HQ_transcript/118287|m.24704 | UnnamedSample_HQ_transcript/118287 | Coverage 0.564 too low. | d8a987107930d8d886b6ac2ed5a180b8 | 165 | Pfam | PF00106 | short chain dehydrogenase | 3 | 119 | 2.1E-24 | T | 22-09-2020 | IPR002347 | Short-chain dehydrogenase/reductase SDR |
| UnnamedSample_HQ_transcript/30515|m.9587 | UnnamedSample_HQ_transcript/30515 | Coverage 0.899 too low. | b8f12a1209c05667a9715c65b7e7699a | 595 | Pfam | PF01337 | Barstar (barnase inhibitor) | 244 | 310 | 4.0E-5 | T | 22-09-2020 | IPR000468 | Barstar (barnase inhibitor) |
| UnnamedSample_HQ_transcript/64361|m.16923 | UnnamedSample_HQ_transcript/64361 | Identity 0.739 too low. | 0700e20da6b2a73a793d5aea5a1f1568 | 270 | Pfam | PF11901 | Protein of unknown function (DUF3421) | 143 | 254 | 1.3E-32 | T | 22-09-2020 | IPR024518 | Domain of unknown function DUF3421 |
| UnnamedSample_HQ_transcript/64361|m.16923 | UnnamedSample_HQ_transcript/64361 | Identity 0.739 too low. | 0700e20da6b2a73a793d5aea5a1f1568 | 270 | Pfam | PF11901 | Protein of unknown function (DUF3421) | 115 | 177 | 9.2E-17 | T | 22-09-2020 | IPR024518 | Domain of unknown function DUF3421 |
| UnnamedSample_HQ_transcript/63022|m.16630 | UnnamedSample_HQ_transcript/63022 | Coverage 0.926 too low. | f7e86972d97567796a301e460f4ef2bf | 571 | Pfam | PF00012 | Hsp70 protein | 6 | 570 | 1.0E-257 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/76974|m.19200 | UnnamedSample_HQ_transcript/76974 | Coverage 0.091 too low. | fa4edd191d1cb92338be5fabaa8b6cd7 | 438 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 61 | 142 | 1.2E-7 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/76974|m.19200 | UnnamedSample_HQ_transcript/76974 | Coverage 0.091 too low. | fa4edd191d1cb92338be5fabaa8b6cd7 | 438 | Pfam | PF00372 | Hemocyanin, copper containing domain | 153 | 268 | 2.8E-18 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/76974|m.19200 | UnnamedSample_HQ_transcript/76974 | Coverage 0.091 too low. | fa4edd191d1cb92338be5fabaa8b6cd7 | 438 | Pfam | PF03723 | Hemocyanin, ig-like domain | 349 | 433 | 1.7E-14 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/4646|m.2050 | UnnamedSample_HQ_transcript/4646 | Identity 0.838 too low. | e4b1dcc4689d6af7cf1653c83da2bd60 | 352 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 17 | 74 | 2.4E-15 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/4646|m.2050 | UnnamedSample_HQ_transcript/4646 | Identity 0.838 too low. | e4b1dcc4689d6af7cf1653c83da2bd60 | 352 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 8.1E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/4465|m.1985 | UnnamedSample_HQ_transcript/4465 | Identity 0.840 too low. | e4b1dcc4689d6af7cf1653c83da2bd60 | 352 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 17 | 74 | 2.4E-15 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/4465|m.1985 | UnnamedSample_HQ_transcript/4465 | Identity 0.840 too low. | e4b1dcc4689d6af7cf1653c83da2bd60 | 352 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 8.1E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/5718|m.2429 | UnnamedSample_HQ_transcript/5718 | Identity 0.832 too low. | e4b1dcc4689d6af7cf1653c83da2bd60 | 352 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 17 | 74 | 2.4E-15 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/5718|m.2429 | UnnamedSample_HQ_transcript/5718 | Identity 0.832 too low. | e4b1dcc4689d6af7cf1653c83da2bd60 | 352 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 8.1E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/4795|m.2113 | UnnamedSample_HQ_transcript/4795 | Coverage 0.925 too low. | d2ff6edff862b1794171ae3b3dbe7e29 | 1476 | Pfam | PF01835 | MG2 domain | 148 | 239 | 3.2E-16 | T | 22-09-2020 | IPR002890 | Macroglobulin domain |
| UnnamedSample_HQ_transcript/4795|m.2113 | UnnamedSample_HQ_transcript/4795 | Coverage 0.925 too low. | d2ff6edff862b1794171ae3b3dbe7e29 | 1476 | Pfam | PF07677 | A-macroglobulin receptor binding domain | 1324 | 1413 | 5.1E-22 | T | 22-09-2020 | IPR009048 | Alpha-macroglobulin, receptor-binding |
| UnnamedSample_HQ_transcript/4795|m.2113 | UnnamedSample_HQ_transcript/4795 | Coverage 0.925 too low. | d2ff6edff862b1794171ae3b3dbe7e29 | 1476 | Pfam | PF07678 | A-macroglobulin TED domain | 917 | 1219 | 3.9E-99 | T | 22-09-2020 | IPR011626 | Alpha-macroglobulin-like, TED domain |
| UnnamedSample_HQ_transcript/4795|m.2113 | UnnamedSample_HQ_transcript/4795 | Coverage 0.925 too low. | d2ff6edff862b1794171ae3b3dbe7e29 | 1476 | Pfam | PF17789 | Macroglobulin domain MG4 | 363 | 447 | 1.4E-6 | T | 22-09-2020 | IPR040839 | Macroglobulin domain MG4 |
| UnnamedSample_HQ_transcript/4795|m.2113 | UnnamedSample_HQ_transcript/4795 | Coverage 0.925 too low. | d2ff6edff862b1794171ae3b3dbe7e29 | 1476 | Pfam | PF00207 | Alpha-2-macroglobulin family | 710 | 801 | 4.0E-27 | T | 22-09-2020 | IPR001599 | Alpha-2-macroglobulin |
| UnnamedSample_HQ_transcript/4795|m.2113 | UnnamedSample_HQ_transcript/4795 | Coverage 0.925 too low. | d2ff6edff862b1794171ae3b3dbe7e29 | 1476 | Pfam | PF07703 | Alpha-2-macroglobulin bait region domain | 467 | 602 | 3.6E-18 | T | 22-09-2020 | IPR011625 | Alpha-2-macroglobulin, bait region domain |
| UnnamedSample_HQ_transcript/4795|m.2113 | UnnamedSample_HQ_transcript/4795 | Coverage 0.925 too low. | d2ff6edff862b1794171ae3b3dbe7e29 | 1476 | Pfam | PF17791 | Macroglobulin domain MG3 | 241 | 289 | 1.6E-15 | T | 22-09-2020 | IPR041555 | Macroglobulin domain MG3 |
| UnnamedSample_HQ_transcript/105687|m.23305 | UnnamedSample_HQ_transcript/105687 | Coverage 0.857 too low. | ea6a9a7266f2596c16ac008e6da31eeb | 160 | Pfam | PF01130 | CD36 family | 92 | 154 | 6.2E-10 | T | 22-09-2020 | IPR002159 | CD36 family |
| UnnamedSample_HQ_transcript/113154|m.24201 | UnnamedSample_HQ_transcript/113154 | Coverage 0.840 too low. | ea6a9a7266f2596c16ac008e6da31eeb | 160 | Pfam | PF01130 | CD36 family | 92 | 154 | 6.2E-10 | T | 22-09-2020 | IPR002159 | CD36 family |
| UnnamedSample_HQ_transcript/107453|m.23516 | UnnamedSample_HQ_transcript/107453 | Coverage 0.859 too low. | ea6a9a7266f2596c16ac008e6da31eeb | 160 | Pfam | PF01130 | CD36 family | 92 | 154 | 6.2E-10 | T | 22-09-2020 | IPR002159 | CD36 family |
| UnnamedSample_HQ_transcript/92665|m.21617 | UnnamedSample_HQ_transcript/92665 | Coverage 0.898 too low. | ea6a9a7266f2596c16ac008e6da31eeb | 160 | Pfam | PF01130 | CD36 family | 92 | 154 | 6.2E-10 | T | 22-09-2020 | IPR002159 | CD36 family |
| UnnamedSample_HQ_transcript/100048|m.22645 | UnnamedSample_HQ_transcript/100048 | Coverage 0.878 too low. | ea6a9a7266f2596c16ac008e6da31eeb | 160 | Pfam | PF01130 | CD36 family | 92 | 154 | 6.2E-10 | T | 22-09-2020 | IPR002159 | CD36 family |
| UnnamedSample_HQ_transcript/121052|m.24928 | UnnamedSample_HQ_transcript/121052 | Coverage 0.691 too low. | af5001643538000552f7ac5e31d91aed | 181 | Pfam | PF00626 | Gelsolin repeat | 17 | 94 | 3.4E-15 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/6761|m.2791 | UnnamedSample_HQ_transcript/6761 | Coverage 0.117 too low. | 341f8b67e31891a52ab392c4ab945bc2 | 1007 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 787 | 990 | 2.7E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/6761|m.2791 | UnnamedSample_HQ_transcript/6761 | Coverage 0.117 too low. | 341f8b67e31891a52ab392c4ab945bc2 | 1007 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 350 | 717 | 8.9E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/6761|m.2791 | UnnamedSample_HQ_transcript/6761 | Coverage 0.117 too low. | 341f8b67e31891a52ab392c4ab945bc2 | 1007 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 5 | 72 | 2.3E-21 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/6761|m.2791 | UnnamedSample_HQ_transcript/6761 | Coverage 0.117 too low. | 341f8b67e31891a52ab392c4ab945bc2 | 1007 | Pfam | PF00122 | E1-E2 ATPase | 126 | 332 | 4.9E-53 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/275|m.231 | UnnamedSample_HQ_transcript/275 | Coverage 0.305 too low. | 07ac2c3e550d29b09b25b63755466633 | 1436 | Pfam | PF06009 | Laminin Domain II | 352 | 474 | 2.0E-9 | T | 22-09-2020 | IPR010307 | Laminin domain II |
| UnnamedSample_HQ_transcript/275|m.231 | UnnamedSample_HQ_transcript/275 | Coverage 0.305 too low. | 07ac2c3e550d29b09b25b63755466633 | 1436 | Pfam | PF02210 | Laminin G domain | 1111 | 1237 | 1.4E-22 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/275|m.231 | UnnamedSample_HQ_transcript/275 | Coverage 0.305 too low. | 07ac2c3e550d29b09b25b63755466633 | 1436 | Pfam | PF02210 | Laminin G domain | 488 | 642 | 6.3E-16 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/275|m.231 | UnnamedSample_HQ_transcript/275 | Coverage 0.305 too low. | 07ac2c3e550d29b09b25b63755466633 | 1436 | Pfam | PF02210 | Laminin G domain | 1288 | 1415 | 5.6E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/275|m.231 | UnnamedSample_HQ_transcript/275 | Coverage 0.305 too low. | 07ac2c3e550d29b09b25b63755466633 | 1436 | Pfam | PF02210 | Laminin G domain | 891 | 1010 | 3.4E-12 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/275|m.231 | UnnamedSample_HQ_transcript/275 | Coverage 0.305 too low. | 07ac2c3e550d29b09b25b63755466633 | 1436 | Pfam | PF02210 | Laminin G domain | 710 | 831 | 3.4E-21 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/91598|m.21487 | UnnamedSample_HQ_transcript/91598 | Identity 0.949 too low. | 762805dc9098aa773abf5fded1392b1c | 181 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 1 | 179 | 2.0E-34 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/113486|m.24240 | UnnamedSample_HQ_transcript/113486 | Coverage 0.984 too low. | 762805dc9098aa773abf5fded1392b1c | 181 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 1 | 179 | 2.0E-34 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/100654|m.22722 | UnnamedSample_HQ_transcript/100654 | Identity 0.942 too low. | 762805dc9098aa773abf5fded1392b1c | 181 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 1 | 179 | 2.0E-34 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/78586|m.19478 | UnnamedSample_HQ_transcript/78586 | Identity 0.948 too low. | 762805dc9098aa773abf5fded1392b1c | 181 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 1 | 179 | 2.0E-34 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/104503|m.23167 | UnnamedSample_HQ_transcript/104503 | Identity 0.939 too low. | 762805dc9098aa773abf5fded1392b1c | 181 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 1 | 179 | 2.0E-34 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/79468|m.19622 | UnnamedSample_HQ_transcript/79468 | Coverage 0.475 too low. | cf6c5d8c92b2726742f51a74abfd245d | 467 | Pfam | PF00028 | Cadherin domain | 147 | 232 | 1.9E-9 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/50826|m.14210 | UnnamedSample_HQ_transcript/50826 | Coverage 0.690 too low. | 8a94e0a19e427b99e53e5b5598bb58a7 | 418 | Pfam | PF00170 | bZIP transcription factor | 347 | 406 | 3.3E-10 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/115451|m.24440 | UnnamedSample_HQ_transcript/115451 | Coverage 0.927 too low. | af6a093e8f7feef53d777fd670b54ca4 | 230 | Pfam | PF00316 | Fructose-1-6-bisphosphatase, N-terminal domain | 11 | 200 | 7.0E-77 | T | 22-09-2020 | IPR033391 | Fructose-1-6-bisphosphatase class I, N-terminal |
| UnnamedSample_HQ_transcript/87049|m.20807 | UnnamedSample_HQ_transcript/87049 | Coverage 0.654 too low. | 5ea81b87a8298270b0a3a40a1603a870 | 295 | Pfam | PF01151 | GNS1/SUR4 family | 32 | 270 | 1.1E-59 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/31960|m.9938 | UnnamedSample_HQ_transcript/31960 | Coverage 0.821 too low. | 5ea81b87a8298270b0a3a40a1603a870 | 295 | Pfam | PF01151 | GNS1/SUR4 family | 32 | 270 | 1.1E-59 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/85157|m.20518 | UnnamedSample_HQ_transcript/85157 | Coverage 0.664 too low. | 5ea81b87a8298270b0a3a40a1603a870 | 295 | Pfam | PF01151 | GNS1/SUR4 family | 32 | 270 | 1.1E-59 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/22346|m.7527 | UnnamedSample_HQ_transcript/22346 | Coverage 0.078 too low. | 91e1bec561e1971503d98033795b6bc2 | 347 | Pfam | PF01151 | GNS1/SUR4 family | 29 | 264 | 1.5E-59 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/203|m.181 | UnnamedSample_HQ_transcript/203 | Unmapped. | deca7f444974f58a17ba23eb52b711fd | 2177 | Pfam | PF13604 | AAA domain | 1263 | 1421 | 1.4E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/203|m.181 | UnnamedSample_HQ_transcript/203 | Unmapped. | deca7f444974f58a17ba23eb52b711fd | 2177 | Pfam | PF13087 | AAA domain | 1443 | 1614 | 2.1E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/203|m.181 | UnnamedSample_HQ_transcript/203 | Unmapped. | deca7f444974f58a17ba23eb52b711fd | 2177 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 858 | 4.7E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/8602|m.3380 | UnnamedSample_HQ_transcript/8602 | Coverage 0.774 too low. | 41c2ec651fdac1a6d2a6ce44b2e47b40 | 527 | Pfam | PF00567 | Tudor domain | 278 | 358 | 5.4E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/8602|m.3380 | UnnamedSample_HQ_transcript/8602 | Coverage 0.774 too low. | 41c2ec651fdac1a6d2a6ce44b2e47b40 | 527 | Pfam | PF00567 | Tudor domain | 401 | 504 | 8.4E-12 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/8602|m.3380 | UnnamedSample_HQ_transcript/8602 | Coverage 0.774 too low. | 41c2ec651fdac1a6d2a6ce44b2e47b40 | 527 | Pfam | PF00567 | Tudor domain | 75 | 183 | 3.5E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/45066|m.12925 | UnnamedSample_HQ_transcript/45066 | Coverage 0.728 too low. | 1407fae036a09d2fc607b52cd5c6b752 | 685 | Pfam | PF00626 | Gelsolin repeat | 72 | 132 | 1.2E-5 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/45066|m.12925 | UnnamedSample_HQ_transcript/45066 | Coverage 0.728 too low. | 1407fae036a09d2fc607b52cd5c6b752 | 685 | Pfam | PF00626 | Gelsolin repeat | 482 | 559 | 5.8E-5 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/45066|m.12925 | UnnamedSample_HQ_transcript/45066 | Coverage 0.728 too low. | 1407fae036a09d2fc607b52cd5c6b752 | 685 | Pfam | PF00626 | Gelsolin repeat | 194 | 261 | 3.3E-10 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/45066|m.12925 | UnnamedSample_HQ_transcript/45066 | Coverage 0.728 too low. | 1407fae036a09d2fc607b52cd5c6b752 | 685 | Pfam | PF00626 | Gelsolin repeat | 595 | 670 | 1.1E-11 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/61153|m.16292 | UnnamedSample_HQ_transcript/61153 | Coverage 0.669 too low. | 98688047f6d078caeabb8a1bdaff00f3 | 432 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/57297|m.15504 | UnnamedSample_HQ_transcript/57297 | Coverage 0.747 too low. | 3bb761f98b61febbacd3b4b6fcb05259 | 341 | Pfam | PF14681 | Uracil phosphoribosyltransferase | 133 | 336 | 1.3E-73 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/57297|m.15504 | UnnamedSample_HQ_transcript/57297 | Coverage 0.747 too low. | 3bb761f98b61febbacd3b4b6fcb05259 | 341 | Pfam | PF00485 | Phosphoribulokinase / Uridine kinase family | 1 | 91 | 4.3E-26 | T | 22-09-2020 | IPR006083 | Phosphoribulokinase/uridine kinase |
| UnnamedSample_HQ_transcript/8866|m.3468 | UnnamedSample_HQ_transcript/8866 | Coverage 0.187 too low. | 162e64905c5022bd357ee9bab3244d11 | 309 | Pfam | PF01437 | Plexin repeat | 176 | 203 | 6.2E-5 | T | 22-09-2020 | IPR002165 | Plexin repeat |
| UnnamedSample_HQ_transcript/8866|m.3468 | UnnamedSample_HQ_transcript/8866 | Coverage 0.187 too low. | 162e64905c5022bd357ee9bab3244d11 | 309 | Pfam | PF01403 | Sema domain | 2 | 154 | 8.5E-37 | T | 22-09-2020 | IPR001627 | Sema domain |
| UnnamedSample_HQ_transcript/68607|m.17686 | UnnamedSample_HQ_transcript/68607 | Identity 0.728 too low. | bfda230e39ece9469b0b6e9fe3bee15c | 472 | Pfam | PF07994 | Myo-inositol-1-phosphate synthase | 1 | 281 | 5.0E-69 | T | 22-09-2020 | IPR002587 | Myo-inositol-1-phosphate synthase |
| UnnamedSample_HQ_transcript/68607|m.17686 | UnnamedSample_HQ_transcript/68607 | Identity 0.728 too low. | bfda230e39ece9469b0b6e9fe3bee15c | 472 | Pfam | PF01658 | Myo-inositol-1-phosphate synthase | 98 | 211 | 4.5E-42 | T | 22-09-2020 | IPR013021 | Myo-inositol-1-phosphate synthase, GAPDH-like |
| UnnamedSample_HQ_transcript/28060|m.8986 | UnnamedSample_HQ_transcript/28060 | Coverage 0.034 too low. | 1cb2e1254cfb3b762afa165b3d68ddaf | 812 | Pfam | PF12054 | Domain of unknown function (DUF3535) | 476 | 812 | 3.3E-83 | T | 22-09-2020 | IPR022707 | Domain of unknown function DUF3535 |
| UnnamedSample_HQ_transcript/44683|m.12851 | UnnamedSample_HQ_transcript/44683 | Coverage 0.864 too low. | baa4482d647e3c39d17b87c7aff3e85e | 319 | Pfam | PF00554 | Rel homology DNA-binding domain | 174 | 301 | 1.3E-24 | T | 22-09-2020 | IPR011539 | Rel homology domain (RHD), DNA-binding domain |
| UnnamedSample_HQ_transcript/6434|m.2680 | UnnamedSample_HQ_transcript/6434 | Coverage 0.934 too low. | 91be9233e18abb64b094ac974c4f2de7 | 1226 | Pfam | PF00412 | LIM domain | 1157 | 1217 | 4.3E-5 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/9596|m.3705 | UnnamedSample_HQ_transcript/9596 | Coverage 0.169 too low. | 660f19e1fde6512f54011dab0910f3d7 | 923 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 134 | 196 | 2.9E-11 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/9596|m.3705 | UnnamedSample_HQ_transcript/9596 | Coverage 0.169 too low. | 660f19e1fde6512f54011dab0910f3d7 | 923 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 643 | 705 | 7.8E-8 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/9596|m.3705 | UnnamedSample_HQ_transcript/9596 | Coverage 0.169 too low. | 660f19e1fde6512f54011dab0910f3d7 | 923 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 284 | 343 | 5.6E-11 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/9596|m.3705 | UnnamedSample_HQ_transcript/9596 | Coverage 0.169 too low. | 660f19e1fde6512f54011dab0910f3d7 | 923 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 804 | 866 | 2.2E-8 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/9596|m.3705 | UnnamedSample_HQ_transcript/9596 | Coverage 0.169 too low. | 660f19e1fde6512f54011dab0910f3d7 | 923 | Pfam | PF12901 | SUZ-C motif | 887 | 910 | 5.6E-5 | T | 22-09-2020 | IPR024642 | SUZ-C domain |
| UnnamedSample_HQ_transcript/11639|m.4373 | UnnamedSample_HQ_transcript/11639 | Coverage 0.130 too low. | 660f19e1fde6512f54011dab0910f3d7 | 923 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 134 | 196 | 2.9E-11 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/11639|m.4373 | UnnamedSample_HQ_transcript/11639 | Coverage 0.130 too low. | 660f19e1fde6512f54011dab0910f3d7 | 923 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 643 | 705 | 7.8E-8 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/11639|m.4373 | UnnamedSample_HQ_transcript/11639 | Coverage 0.130 too low. | 660f19e1fde6512f54011dab0910f3d7 | 923 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 284 | 343 | 5.6E-11 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/11639|m.4373 | UnnamedSample_HQ_transcript/11639 | Coverage 0.130 too low. | 660f19e1fde6512f54011dab0910f3d7 | 923 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 804 | 866 | 2.2E-8 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/11639|m.4373 | UnnamedSample_HQ_transcript/11639 | Coverage 0.130 too low. | 660f19e1fde6512f54011dab0910f3d7 | 923 | Pfam | PF12901 | SUZ-C motif | 887 | 910 | 5.6E-5 | T | 22-09-2020 | IPR024642 | SUZ-C domain |
| UnnamedSample_HQ_transcript/18547|m.6458 | UnnamedSample_HQ_transcript/18547 | Coverage 0.059 too low. | 3597285b0ec5a2eb273ad4bc1f886c67 | 886 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 104 | 278 | 3.3E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/95526|m.22028 | UnnamedSample_HQ_transcript/95526 | Coverage 0.486 too low. | bfe2d13f5b8d8787bf284a5b015fbb1f | 231 | Pfam | PF00501 | AMP-binding enzyme | 4 | 81 | 3.4E-15 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/12018|m.4500 | UnnamedSample_HQ_transcript/12018 | Unmapped. | d21d522c7aab0184dbe88d9c63b60d19 | 1221 | Pfam | PF00910 | RNA helicase | 839 | 947 | 4.1E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/12018|m.4500 | UnnamedSample_HQ_transcript/12018 | Unmapped. | d21d522c7aab0184dbe88d9c63b60d19 | 1221 | Pfam | PF08762 | CRPV capsid protein like | 215 | 425 | 5.9E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/22977|m.7683 | UnnamedSample_HQ_transcript/22977 | Unmapped. | 6e9fb9bff3ceb76e06b5f7563a7fe7c3 | 1020 | Pfam | PF02142 | MGS-like domain | 903 | 987 | 8.1E-19 | T | 22-09-2020 | IPR011607 | Methylglyoxal synthase-like domain |
| UnnamedSample_HQ_transcript/22977|m.7683 | UnnamedSample_HQ_transcript/22977 | Unmapped. | 6e9fb9bff3ceb76e06b5f7563a7fe7c3 | 1020 | Pfam | PF02787 | Carbamoyl-phosphate synthetase large chain, oligomerisation domain | 373 | 451 | 1.3E-23 | T | 22-09-2020 | IPR005480 | Carbamoyl-phosphate synthetase, large subunit oligomerisation domain |
| UnnamedSample_HQ_transcript/22977|m.7683 | UnnamedSample_HQ_transcript/22977 | Unmapped. | 6e9fb9bff3ceb76e06b5f7563a7fe7c3 | 1020 | Pfam | PF02786 | Carbamoyl-phosphate synthase L chain, ATP binding domain | 620 | 822 | 1.1E-37 | T | 22-09-2020 | IPR005479 | Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain |
| UnnamedSample_HQ_transcript/22977|m.7683 | UnnamedSample_HQ_transcript/22977 | Unmapped. | 6e9fb9bff3ceb76e06b5f7563a7fe7c3 | 1020 | Pfam | PF02786 | Carbamoyl-phosphate synthase L chain, ATP binding domain | 74 | 280 | 5.8E-75 | T | 22-09-2020 | IPR005479 | Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain |
| UnnamedSample_HQ_transcript/62439|m.16530 | UnnamedSample_HQ_transcript/62439 | Coverage 0.878 too low. | 7b6cac69a6441d831a67da72e6edb343 | 456 | Pfam | PF08174 | Cell division protein anillin | 56 | 198 | 8.8E-45 | T | 22-09-2020 | IPR012966 | Anillin homology domain |
| UnnamedSample_HQ_transcript/6463|m.2689 | UnnamedSample_HQ_transcript/6463 | Coverage 0.825 too low. | 23969003d2161075f118b801361137a1 | 769 | Pfam | PF00394 | Multicopper oxidase | 336 | 485 | 4.7E-27 | T | 22-09-2020 | IPR001117 | Multicopper oxidase, type 1 |
| UnnamedSample_HQ_transcript/6463|m.2689 | UnnamedSample_HQ_transcript/6463 | Coverage 0.825 too low. | 23969003d2161075f118b801361137a1 | 769 | Pfam | PF07731 | Multicopper oxidase | 590 | 744 | 2.1E-31 | T | 22-09-2020 | IPR011706 | Multicopper oxidase, type 2 |
| UnnamedSample_HQ_transcript/6463|m.2689 | UnnamedSample_HQ_transcript/6463 | Coverage 0.825 too low. | 23969003d2161075f118b801361137a1 | 769 | Pfam | PF07732 | Multicopper oxidase | 209 | 319 | 5.5E-36 | T | 22-09-2020 | IPR011707 | Multicopper oxidase, type 3 |
| UnnamedSample_HQ_transcript/110122|m.23849 | UnnamedSample_HQ_transcript/110122 | Coverage 0.782 too low. | 24cbed04f84192bdd1d3c096176a32c0 | 205 | Pfam | PF00083 | Sugar (and other) transporter | 40 | 187 | 7.3E-6 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/24870|m.8185 | UnnamedSample_HQ_transcript/24870 | Coverage 0.296 too low. | 0ab07a1bfb1fe9439cef62ecd07998b5 | 917 | Pfam | PF13646 | HEAT repeats | 610 | 700 | 7.8E-13 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/24870|m.8185 | UnnamedSample_HQ_transcript/24870 | Coverage 0.296 too low. | 0ab07a1bfb1fe9439cef62ecd07998b5 | 917 | Pfam | PF18004 | 26S proteasome regulatory subunit RPN2 C-terminal domain | 796 | 916 | 1.1E-23 | T | 22-09-2020 | IPR040623 | 26S proteasome regulatory subunit RPN2, C-terminal |
| UnnamedSample_HQ_transcript/77617|m.19310 | UnnamedSample_HQ_transcript/77617 | Coverage 0.698 too low. | f19aece5dafffe8272164bc53efc502a | 412 | Pfam | PF00089 | Trypsin | 161 | 406 | 3.0E-51 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/82289|m.20077 | UnnamedSample_HQ_transcript/82289 | Coverage 0.734 too low. | f19aece5dafffe8272164bc53efc502a | 412 | Pfam | PF00089 | Trypsin | 161 | 406 | 3.0E-51 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/80957|m.19872 | UnnamedSample_HQ_transcript/80957 | Coverage 0.143 too low. | 5410e726851d5f0a72fbb2d5a3a29700 | 391 | Pfam | PF02958 | Ecdysteroid kinase | 37 | 306 | 5.9E-59 | T | 22-09-2020 | IPR004119 | Ecdysteroid kinase-like |
| UnnamedSample_HQ_transcript/6644|m.2759 | UnnamedSample_HQ_transcript/6644 | Coverage 0.920 too low. | 19215a60ccdaa893cd054557e89d337c | 1014 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 790 | 998 | 6.7E-45 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/6644|m.2759 | UnnamedSample_HQ_transcript/6644 | Coverage 0.920 too low. | 19215a60ccdaa893cd054557e89d337c | 1014 | Pfam | PF00122 | E1-E2 ATPase | 155 | 345 | 5.4E-43 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/6644|m.2759 | UnnamedSample_HQ_transcript/6644 | Coverage 0.920 too low. | 19215a60ccdaa893cd054557e89d337c | 1014 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 34 | 102 | 7.9E-17 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/6644|m.2759 | UnnamedSample_HQ_transcript/6644 | Coverage 0.920 too low. | 19215a60ccdaa893cd054557e89d337c | 1014 | Pfam | PF13246 | Cation transport ATPase (P-type) | 417 | 512 | 1.3E-23 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5257|m.2282 | UnnamedSample_HQ_transcript/5257 | Unmapped. | 662103e8555c200855e82a7d64e12fb6 | 1442 | Pfam | PF00910 | RNA helicase | 14 | 122 | 5.1E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/5257|m.2282 | UnnamedSample_HQ_transcript/5257 | Unmapped. | 662103e8555c200855e82a7d64e12fb6 | 1442 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 1076 | 1401 | 1.9E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
